Refractory viral warts
Conditions
Interventions
Patients with refractory viral warts:Graphene-simulated human far-infrared radiation patch therapy
Sponsors
Xiang'an Hospital Affiliated to Xiamen University
Eligibility
Sex/Gender
All
Age
6 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria of viral warts; 2. The patients who have no effect or relapse after routine treatment such as cryotherapy and topical medicine; 3. Patients aged 6-65 years, both male and female; 4. Patients who signed informed consent (under 14 years old, informed consent should be signed by guardian).
Exclusion criteria
Exclusion criteria: 1. In patients with local skin lesions complicated with infection, severe exudation and other skin diseases affecting the experimental results were found; 2. Patients with severe liver and kidney dysfunction, low immune function and mental disorders; 3. Patients who received systemic or topical corticosteroids or immunosuppressants 2 weeks before treatment; 4. Pregnant women and lactation patients; 5. Patients with severe liver and kidney diseases, autoimmune diseases (such as systemic lupus erythematosus, rheumatoid disease, etc.), HIV infection and malignant tumor; 6. Patients who have been allergic to this product and its related components in the past; 7. Patients who are unable to use in accordance with the requirements of clinical trials and comply with the provisions of drug restriction; 8. Patients unable to complete the treatment plan and follow-up observation; 9. Patients who do not meet the requirements of this study or are unable to participate in the study due to other reasons are judged by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction rate of patients;Degree of discomfort relief; | — |
Countries
China
Contacts
Public ContactShan Shijun
Xiang'an Hospital Affiliated to Xiamen University
Outcome results
None listed